Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A combinatorial culture strategy to develop pseudomyxoma peritonei organoid models.
Varinelli L, Di Bella M, Guaglio M, Battistessa D, Pisati F, Cavalleri T, Milione M, Martínez-Quintanilla J, Caswell PT, Baratti D, Kusamura S, Deraco M, Gariboldi M; PMPnet Group. Varinelli L, et al. Among authors: martinez quintanilla j. J Surg Oncol. 2024 Oct 3. doi: 10.1002/jso.27850. Online ahead of print. J Surg Oncol. 2024. PMID: 39360464
Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei.
Martínez-Quintanilla J, Cabot D, Sabia D, Arqués O; PMPnet Group; Vergés J, Chicote I, Bijelic L; PMPnet Group; Cabellos L, Alcántara AM, Ramos I, Barrios P, Crusellas O, Palacio LM; PMPnet Group; Cámara JA, Barriuso J; PMPnet Group; Jiménez JJ, Muñoz-Torres P, Nonell L, Flores R, Médico E, Guaglio M; PMPnet Group; Ros J, Élez E, Tabernero J, Aziz O, Deraco M, Palmer HG; PMPnet Group; PMPnet Group. Martínez-Quintanilla J, et al. Clin Cancer Res. 2024 Sep 13;30(18):4082-4099. doi: 10.1158/1078-0432.CCR-23-4072. Clin Cancer Res. 2024. PMID: 39018564 Free PMC article.
Undetectable circulating tumor DNA confirms the inability of pseudomyxoma peritonei to systemic dissemination.
Villarejo Campos P, Vázquez-Borrego MC, Martínez-Quintanilla J, Cabot D, Romero-Ruíz A, Granados-Rodríguez M, Bura FI, García-Arranz M, García-Olmo D, Arjona-Sánchez A. Villarejo Campos P, et al. Among authors: martinez quintanilla j. Eur J Surg Oncol. 2024 Jul;50(7):108395. doi: 10.1016/j.ejso.2024.108395. Epub 2024 May 9. Eur J Surg Oncol. 2024. PMID: 38735236
Editor's Note: Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas.
Choi SH, Stuckey DW, Pignatta S, Reinshagen C, Khalsa JK, Roozendaal N, Martinez-Quintanilla J, Tamura K, Keles E, Shah K. Choi SH, et al. Among authors: martinez quintanilla j. Clin Cancer Res. 2024 May 1;30(9):1993. doi: 10.1158/1078-0432.CCR-24-0858. Clin Cancer Res. 2024. PMID: 38690598 No abstract available.
DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype.
Cuesta-Borràs E, Salvans C, Arqués O, Chicote I, Ramírez L, Cabellos L, Martínez-Quintanilla J, Mur-Espinosa A, García-Álvarez A, Hernando J, Tejedor JR, Mirallas O, Élez E, Fraga MF, Tabernero J, Nuciforo P, Capdevila J, Palmer HG, Puig I. Cuesta-Borràs E, et al. Among authors: martinez quintanilla j. Cell Rep. 2023 Aug 29;42(8):112927. doi: 10.1016/j.celrep.2023.112927. Epub 2023 Aug 1. Cell Rep. 2023. PMID: 37537841 Free article.
Efecto del confinamiento durante la pandemia de Covid-19 en los niveles séricos de lípidos y composición corporal de estudiantes universitarios.
Tirado-Aguilar RD, Valdés-Velázquez JA, Segovia-Hernández HU, Martínez-Quintanilla JH, Pérez-García E, Pierdant-Pérez M. Tirado-Aguilar RD, et al. Among authors: martinez quintanilla jh. Salud Publica Mex. 2023 Jan 2;65(1, ene-feb):103-105. doi: 10.21149/14180. Salud Publica Mex. 2023. PMID: 36750067 Spanish.
Oncolytic viruses: overcoming translational challenges.
Martinez-Quintanilla J, Seah I, Chua M, Shah K. Martinez-Quintanilla J, et al. J Clin Invest. 2019 Mar 4;129(4):1407-1418. doi: 10.1172/JCI122287. eCollection 2019 Mar 4. J Clin Invest. 2019. PMID: 30829653 Free PMC article. Review.
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence.
Puig I, Tenbaum SP, Chicote I, Arqués O, Martínez-Quintanilla J, Cuesta-Borrás E, Ramírez L, Gonzalo P, Soto A, Aguilar S, Eguizabal C, Caratù G, Prat A, Argilés G, Landolfi S, Casanovas O, Serra V, Villanueva A, Arroyo AG, Terracciano L, Nuciforo P, Seoane J, Recio JA, Vivancos A, Dienstmann R, Tabernero J, Palmer HG. Puig I, et al. Among authors: martinez quintanilla j. J Clin Invest. 2018 Aug 31;128(9):3887-3905. doi: 10.1172/JCI96393. Epub 2018 Aug 6. J Clin Invest. 2018. PMID: 29944140 Free PMC article.
24 results